More Latest News

Important notice regarding Inveltys
August 7, 2019

The board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002. Effective August 5, 2019, Licensees are now permitted to prescribe Inveltys. Continue reading


Brand Names not allowed on formulary.
July 23, 2019

The Board of Optometry met on July 18, 2019 in Orlando regarding adding Rocklatan to the formulary. Click here for more information on the formulary. Continue reading